Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro. / Møller, J; Hofmann, B; Langhoff, E; Damgård Jacobsen, K; Ødum, Niels; Dickmeiss, E; Ryder, L P; Thastrup, O; Scharff, O; Foder, B.

In: Scandinavian Journal of Immunology, Vol. 30, No. 4, 1989, p. 441-7.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Møller, J, Hofmann, B, Langhoff, E, Damgård Jacobsen, K, Ødum, N, Dickmeiss, E, Ryder, LP, Thastrup, O, Scharff, O & Foder, B 1989, 'Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro', Scandinavian Journal of Immunology, vol. 30, no. 4, pp. 441-7.

APA

Møller, J., Hofmann, B., Langhoff, E., Damgård Jacobsen, K., Ødum, N., Dickmeiss, E., Ryder, L. P., Thastrup, O., Scharff, O., & Foder, B. (1989). Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro. Scandinavian Journal of Immunology, 30(4), 441-7.

Vancouver

Møller J, Hofmann B, Langhoff E, Damgård Jacobsen K, Ødum N, Dickmeiss E et al. Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro. Scandinavian Journal of Immunology. 1989;30(4):441-7.

Author

Møller, J ; Hofmann, B ; Langhoff, E ; Damgård Jacobsen, K ; Ødum, Niels ; Dickmeiss, E ; Ryder, L P ; Thastrup, O ; Scharff, O ; Foder, B. / Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro. In: Scandinavian Journal of Immunology. 1989 ; Vol. 30, No. 4. pp. 441-7.

Bibtex

@article{147978d0fda111ddb219000ea68e967b,
title = "Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro",
abstract = "This study was undertaken to clarify the mechanism behind the severely decreased lymphocyte proliferative response upon stimulation with mitogens and antigens seen after allogeneic bone marrow transplantation (BMT) in man. We investigated eight BMT patients and eight controls and found that the proliferative response of patient cells was reduced both when the cells were stimulated with phytohaemagglutinin (PHA) and when they were stimulated with a combination of phorbol myristate acetate (PMA), which is an activator of protein kinase C (PKC), and the calcium ionophore A23187, which irreversibly opens for calcium transport into the cell (median relative responses were 41 and 37%, respectively). However, the PHA-induced increase in the concentration of intracellular free calcium in post-BMT cells was not significantly different from the values found in control cells and the expression of interleukin 2 (IL-2) receptors (CD25) was only slightly decreased. However, the production of IL-2 was severely decreased in patient cells after stimulation with A23187/PMA (median 3541 units), although it was higher than in PHA-stimulated control cells (median 354 units). These results show that a direct activation of PKC by PMA combined with an increase in intracellular free calcium by A23187 cannot overcome the lymphocyte proliferation deficiency in cells from patients after allogeneic BMT. The data suggests that the defect is affecting the diacylglycerol pathway considerably more than the inositol triphosphate pathway.",
author = "J M{\o}ller and B Hofmann and E Langhoff and {Damg{\aa}rd Jacobsen}, K and Niels {\O}dum and E Dickmeiss and Ryder, {L P} and O Thastrup and O Scharff and B Foder",
note = "Keywords: Adolescent; Adult; Bone Marrow Transplantation; Calcimycin; Calcium; Cells, Cultured; Child; Female; Humans; Immunologic Deficiency Syndromes; Interleukin-2; Lymphocyte Activation; Male; Phytohemagglutinins; Receptors, Immunologic; Receptors, Interleukin-2; T-Lymphocytes; Tetradecanoylphorbol Acetate",
year = "1989",
language = "English",
volume = "30",
pages = "441--7",
journal = "Scandinavian Journal of Immunology, Supplement",
issn = "0301-6323",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro

AU - Møller, J

AU - Hofmann, B

AU - Langhoff, E

AU - Damgård Jacobsen, K

AU - Ødum, Niels

AU - Dickmeiss, E

AU - Ryder, L P

AU - Thastrup, O

AU - Scharff, O

AU - Foder, B

N1 - Keywords: Adolescent; Adult; Bone Marrow Transplantation; Calcimycin; Calcium; Cells, Cultured; Child; Female; Humans; Immunologic Deficiency Syndromes; Interleukin-2; Lymphocyte Activation; Male; Phytohemagglutinins; Receptors, Immunologic; Receptors, Interleukin-2; T-Lymphocytes; Tetradecanoylphorbol Acetate

PY - 1989

Y1 - 1989

N2 - This study was undertaken to clarify the mechanism behind the severely decreased lymphocyte proliferative response upon stimulation with mitogens and antigens seen after allogeneic bone marrow transplantation (BMT) in man. We investigated eight BMT patients and eight controls and found that the proliferative response of patient cells was reduced both when the cells were stimulated with phytohaemagglutinin (PHA) and when they were stimulated with a combination of phorbol myristate acetate (PMA), which is an activator of protein kinase C (PKC), and the calcium ionophore A23187, which irreversibly opens for calcium transport into the cell (median relative responses were 41 and 37%, respectively). However, the PHA-induced increase in the concentration of intracellular free calcium in post-BMT cells was not significantly different from the values found in control cells and the expression of interleukin 2 (IL-2) receptors (CD25) was only slightly decreased. However, the production of IL-2 was severely decreased in patient cells after stimulation with A23187/PMA (median 3541 units), although it was higher than in PHA-stimulated control cells (median 354 units). These results show that a direct activation of PKC by PMA combined with an increase in intracellular free calcium by A23187 cannot overcome the lymphocyte proliferation deficiency in cells from patients after allogeneic BMT. The data suggests that the defect is affecting the diacylglycerol pathway considerably more than the inositol triphosphate pathway.

AB - This study was undertaken to clarify the mechanism behind the severely decreased lymphocyte proliferative response upon stimulation with mitogens and antigens seen after allogeneic bone marrow transplantation (BMT) in man. We investigated eight BMT patients and eight controls and found that the proliferative response of patient cells was reduced both when the cells were stimulated with phytohaemagglutinin (PHA) and when they were stimulated with a combination of phorbol myristate acetate (PMA), which is an activator of protein kinase C (PKC), and the calcium ionophore A23187, which irreversibly opens for calcium transport into the cell (median relative responses were 41 and 37%, respectively). However, the PHA-induced increase in the concentration of intracellular free calcium in post-BMT cells was not significantly different from the values found in control cells and the expression of interleukin 2 (IL-2) receptors (CD25) was only slightly decreased. However, the production of IL-2 was severely decreased in patient cells after stimulation with A23187/PMA (median 3541 units), although it was higher than in PHA-stimulated control cells (median 354 units). These results show that a direct activation of PKC by PMA combined with an increase in intracellular free calcium by A23187 cannot overcome the lymphocyte proliferation deficiency in cells from patients after allogeneic BMT. The data suggests that the defect is affecting the diacylglycerol pathway considerably more than the inositol triphosphate pathway.

M3 - Journal article

C2 - 2510289

VL - 30

SP - 441

EP - 447

JO - Scandinavian Journal of Immunology, Supplement

JF - Scandinavian Journal of Immunology, Supplement

SN - 0301-6323

IS - 4

ER -

ID: 10637387